Philosophically, I agree that further research and easier access for medical use are good things if marijuana can help alleviate patient suffering. As a primary care physician and a mother,
however, I worry that becoming too lax with restrictions might make it easier to obtain for nonmedical use. The AMA report also reminds us that “whether or not cannabis is a gateway drug to other
substance misuse is controversial.” That’s what makes this issue hit close to my home and my office.
…
The Parliamentary inquiry will look into the issue of „falsified
pandemic“ that was declared by WHO in June 2009 on the advice of its
group of academic experts, SAGE, many of whose members have been
documented to have intense financial ties to the same pharmaceutical
giants such as GlaxoSmithKline, Roche, Novartis, who benefit from the
production of drugs and untested H1N1 vaccines. …
These “inconvenient truth” brain damage medical studies — confirmed
by repeated animal studies, brain scans and autopsies — are now well
known throughout the medical field, but are almost never explained to
the general public, who are often the ones to pay for these expensive
prescriptions.
…
Many of the
medications currently provided are typically associated with
significant medical risk, are often experienced as subjectively
harmful, and their long-term effectiveness remains controversial.
Furthermore, there are widely researched psychosocial alternative
treatments likely to be at least as effective for many, with fewer
harmful effects.” …
Staff members of Governing were reluctant to speak on the record because they did not want to antagonize their new employers. One person who spoke on the condition of anonymity said, “There have been
some eyebrows raised based on the fact that the St. Pete Times has been doing these stories, while simultaneously they have been selling this to a company run by Scientologists.” …
“This drug has the potential to finally open the door to acceptance of the idea that decreased desire can be something that involves a dysfunctional way the brain works, and not only a bad partner,”
said research Jim Pfaus
…
Clozapine is restricted to treating schizophrenia in people who have not
responded to, or are intolerant of, other treatments, as it can cause rare, but
serious side effects. It is also used for treating psychotic illness in people
with Parkinson’s disease where other treatments have not worked.
The width of the therapeutic window determines the clinical
significance of the plasma level changes associated with smoking
and caffeine intake. Compared with olanzapine, clozapine has a
much narrower therapeutic window. Several of clozapine’s side effects
are dose related: plasma levels higher than 1,000 ng per milliliter
have been associated with toxicity, including seizure risk and severe
sedation. …
According to the NSF, this research is important because current imaging
technology, like an MRI or CT scan, do not have the spatial resolution needed to
view tiny structures and require additional external contrast agents to create a
viewable image. Xie’s technique is also a critical breakthrough because typical
fluorescent labels, like green fluorescent protein, which are used to observe
the activity of molecules, can disturb delicate biological pathways, especially
when the protein is bigger than the molecule it is illuminating. …